Blog
Latest articles, insights, and updates from the blog.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
Pharmacokinetics of Ketamine: Absorption, Distribution, Metabolism, and Elimination
A comprehensive overview of ketamine pharmacokinetics across all clinically relevant routes of administration. Covers bioavailability, volume of distribution, hepatic metabolism via CYP enzymes, half-life considerations, and the role of active metabolites.
Renal and Hepatic Dose Adjustments for Low-Dose Ketamine
How is low-dose ketamine adjusted for kidney or liver impairment? Review of pharmacokinetic rationale, dose modification, and monitoring in at-risk patients.
Defining Sub-Anesthetic Ketamine: Dose Ranges and Therapeutic Windows
Comprehensive guide to sub-anesthetic ketamine dose ranges and therapeutic windows, covering pharmacological thresholds, receptor occupancy, and clinical dose-response relationships.
Low-Dose Ketamine for Acute Suicidal Ideation: Clinical Evidence
A review of the clinical trial evidence examining low-dose ketamine as an intervention for acute suicidal ideation. This article evaluates randomized controlled trials, naturalistic studies, and emergency department protocols demonstrating ketamine's rapid anti-suicidal effects.
Ketamine, Neuroplasticity, and Brain-Derived Neurotrophic Factor
How does low-dose ketamine drive neuroplasticity? Review of BDNF, mTOR pathway activation, synaptogenesis, and links to rapid antidepressant effects.
Meta-Analyses of Low-Dose Ketamine for Treatment-Resistant Depression
A comprehensive review of major meta-analyses examining the efficacy and safety of low-dose ketamine in treatment-resistant depression. This overview synthesizes findings across multiple systematic reviews to characterize effect sizes, response rates, and durability of antidepressant outcomes.
Rapid-Onset Antidepressant Mechanisms of Low-Dose Ketamine
An in-depth examination of why and how low-dose ketamine produces antidepressant effects within hours rather than weeks. This article reviews the glutamatergic hypothesis, the role of spontaneous NMDA receptor activity, and emerging theories that distinguish ketamine from conventional antidepressants.
Low-Dose Ketamine for Treatment-Resistant Depression
An evidence-based overview of low-dose ketamine as a rapidly acting antidepressant for patients with treatment-resistant depression, including mechanisms of action, clinical protocols, and outcome data.
Dose-Response Relationships in Low-Dose Ketamine Therapy
An in-depth examination of ketamine dose-response curves across indications including depression, chronic pain, and procedural analgesia. Covers threshold doses, ceiling effects, and how response varies with clinical context.
Patient Selection Criteria for Low-Dose Ketamine Therapy
Evidence-based patient selection criteria for low-dose ketamine therapy, covering indications, contraindications, risk-benefit assessment, and clinical decision-making frameworks.